Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
Aziz Sheikh, Jim McMenamin, J. R. Taylor, et al.
The Lancet (2021) Vol. 397, Iss. 10293, pp. 2461-2462
Open Access | Times Cited: 997

Showing 26-50 of 997 citing articles:

Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
Po Ying Chia, Sean Wei Xiang Ong, Calvin J. Chiew, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 4, pp. 612.e1-612.e7
Open Access | Times Cited: 296
Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
Jun Zhang, Tianshu Xiao, Yongfei Cai, et al.
Science (2021) Vol. 374, Iss. 6573, pp. 1353-1360
Open Access | Times Cited: 289
SARS-CoV-2 Variants, Vaccines, and Host Immunity
Priyal Mistry, Fatima Barmania, Juanita Mellet, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 275
SARS-CoV-2 Variants of Concern
Jun Yong Choi, Davey M. Smith
Yonsei Medical Journal (2021) Vol. 62, Iss. 11, pp. 961-961
Open Access | Times Cited: 274
Risk for Stillbirth Among Women With and Without COVID-19 at Delivery Hospitalization — United States, March 2020–September 2021
Carla L. DeSisto, Bailey Wallace, Regina M. Simeone, et al.
MMWR Morbidity and Mortality Weekly Report (2021) Vol. 70, Iss. 47, pp. 1640-1645
Open Access | Times Cited: 273
Analysis of the Delta Variant B.1.617.2 COVID-19
Shayan Shiehzadegan, Nazanin Alaghemand, Michael Fox, et al.
Clinics and Practice (2021) Vol. 11, Iss. 4, pp. 778-784
Open Access | Times Cited: 263
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design
Aziz Sheikh, Steven Kerr, Mark Woolhouse, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 7, pp. 959-966
Open Access | Times Cited: 240
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
Izumi Kimura, Daichi Yamasoba, Tomokazu Tamura, et al.
Cell (2022) Vol. 185, Iss. 21, pp. 3992-4007.e16
Open Access | Times Cited: 238
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
Baoqi Zeng, Le Gao, Qingxin Zhou, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 234
Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario
Sharifa Nasreen, Hannah Chung, Siyi He, et al.
Nature Microbiology (2022) Vol. 7, Iss. 3, pp. 379-385
Open Access | Times Cited: 231
Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
Karin Bok, Sandra Sitar, Barney S. Graham, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1636-1651
Open Access | Times Cited: 230
Global landscape of SARS-CoV-2 genomic surveillance and data sharing
Zhiyuan Chen, Andrew S. Azman, Xinhua Chen, et al.
Nature Genetics (2022) Vol. 54, Iss. 4, pp. 499-507
Open Access | Times Cited: 226
Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation
Brit Long, Brandon M Carius, Summer Chavez, et al.
The American Journal of Emergency Medicine (2022) Vol. 54, pp. 46-57
Open Access | Times Cited: 219
BNT162b2 Vaccine Booster and Mortality Due to Covid-19
Ronen Arbel, Ariel Hammerman, Ruslan Sergienko, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 26, pp. 2413-2420
Open Access | Times Cited: 217
Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China
Yaping Wang, Ruchong Chen, Fengyu Hu, et al.
EClinicalMedicine (2021) Vol. 40, pp. 101129-101129
Open Access | Times Cited: 216
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Jia Wei, Koen B. Pouwels, Nicole Stoesser, et al.
Nature Medicine (2022) Vol. 28, Iss. 5, pp. 1072-1082
Open Access | Times Cited: 216
Impact of the Delta variant on vaccine efficacy and response strategies
Lianlian Bian, Qiushuang Gao, Fan Gao, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 10, pp. 1201-1209
Open Access | Times Cited: 215
Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study
Hester Allen, Amoolya Vusirikala, Joe Flannagan, et al.
The Lancet Regional Health - Europe (2021) Vol. 12, pp. 100252-100252
Open Access | Times Cited: 208
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
Claudia P. Arevalo, Marcus J. Bolton, Valerie Le Sage, et al.
Science (2022) Vol. 378, Iss. 6622, pp. 899-904
Open Access | Times Cited: 207
SARS-COV-2 Variants: Differences and Potential of Immune Evasion
Sandro Massao Hirabara, Tamires Duarte Afonso Serdan, Renata Gorjão, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 206
The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
Dandan Tian, Yanhong Sun, Jianming Zhou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 191
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant
Paul Elliott, David Haw, Haowei Wang, et al.
Science (2021) Vol. 374, Iss. 6574
Open Access | Times Cited: 176
The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines
Pedro Morais, Hironori Adachi, Yi‐Tao Yu
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 175
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
Gary R. McLean, Jeremy P. Kamil, Benhur Lee, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 174
Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination
Christopher Davis, Nicola Logan, Grace Tyson, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 12, pp. e1010022-e1010022
Open Access | Times Cited: 173

Scroll to top